Company / R&D per Share
Decoy Therapeutics Inc. R&D per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.72
FY2022
5-year range
$0.29 / $4.72
FY2018-FY2022
Trend
+1526.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1527% YoY in FY2022, a notable deviation from the 6-year average annual change of +284%.
Based on SEC 10-K filings.
4.72 in FY2022 with a 5-year CAGR of +44.1%.
Improved from $0.89 to $4.72 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +95.4%
- 5-Year CAGR
- +44.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, r&d per share increased 1526.8% year-over-year.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $4.72 | +1526.8% |
| FY2021 | $0.29 | -67.4% |
| FY2020 | $0.89 | +40.6% |
| FY2019 | $0.63 | -44.7% |
| FY2018 | $1.15 | +50.6% |
| FY2017 | $0.76 | +198.8% |
| FY2016 | $0.25 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026